We are live on ! Find out more
Torren Management

Torren Management Portfolio holdings

AUM $201M Turnover 9.37%
1-Year Est. Return 16.25%
This Fund
S&P 500
This Quarter Est. Return
+0.12%
1 Year Est. Return
+16.25%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$4.15M
Cap. Flow
+$4.57M
Cap. Flow %
2.28%
Top 10 Hldgs %
82.62%
Holding
993
New
45
Increased
106
Reduced
92
Closed
48
Avg Time Held
0.7 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.42%
2 Technology 2.41%
3 Consumer Discretionary 0.73%
4 Financials 0.6%
5 Communication Services 0.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
OBK icon
451
Origin Bancorp
OBK
$1.64B
$3.08K ﹤0.01%
59
– –
2025 Q4
3 quarters
MOG.A icon
452
Moog Inc Class A
MOG.A
$10.2B
$3.08K ﹤0.01%
8
– –
2025 Q4
3 quarters
REGN icon
453
Regeneron Pharmaceuticals
REGN
$93.6B
$3.06K ﹤0.01%
4
– –
2025 Q4
3 quarters
MAZE icon
454
Maze Therapeutics
MAZE
$1.9B
$3.04K ﹤0.01%
112
– –
2025 Q4
3 quarters
JAZZ icon
455
Jazz Pharmaceuticals
JAZZ
$15.1B
$3.01K ﹤0.01%
13
– –
2025 Q4
3 quarters
BCPC icon
456
Balchem Corp
BCPC
$5.56B
$2.97K ﹤0.01%
18
– –
2025 Q4
3 quarters
OKLO icon
457
Oklo
OKLO
$4.38B
$2.96K ﹤0.01%
+80
New +$3.38K
2026 Q3
0 quarters
ED icon
458
Consolidated Edison
ED
$44B
$2.96K ﹤0.01%
29
– –
2025 Q4
3 quarters
HWC icon
459
Hancock Whitney
HWC
$5.73B
$2.94K ﹤0.01%
41
– –
2025 Q4
3 quarters
OMC icon
460
Omnicom Group
OMC
$23.7B
$2.93K ﹤0.01%
40
– –
2025 Q4
3 quarters
CLSK icon
461
CleanSpark
CLSK
$1.58B
$2.92K ﹤0.01%
227
– –
2025 Q4
3 quarters
EVRG icon
462
Evergy
EVRG
$20.5B
$2.91K ﹤0.01%
37
– –
2025 Q4
3 quarters
MLM icon
463
Martin Marietta Materials
MLM
$36.9B
$2.91K ﹤0.01%
6
– –
2025 Q4
3 quarters
TWIN icon
464
Twin Disc
TWIN
$332M
$2.91K ﹤0.01%
111
– –
2025 Q4
3 quarters
WAL icon
465
Western Alliance Bancorporation
WAL
$8.13B
$2.9K ﹤0.01%
39
– –
2025 Q4
3 quarters
DGX icon
466
Quest Diagnostics
DGX
$28.2B
$2.86K ﹤0.01%
12
– –
2025 Q4
3 quarters
IMKTA icon
467
Ingles Markets
IMKTA
$1.56B
$2.85K ﹤0.01%
34
– –
2025 Q4
3 quarters
SXT icon
468
Sensient Technologies
SXT
$5.07B
$2.82K ﹤0.01%
22
– –
2025 Q4
3 quarters
SYY icon
469
Sysco
SYY
$37.8B
$2.82K ﹤0.01%
36
– –
2025 Q4
3 quarters
CROX icon
470
Crocs
CROX
$6.94B
$2.82K ﹤0.01%
24
– –
2025 Q4
3 quarters
HAS icon
471
Hasbro
HAS
$16.6B
$2.81K ﹤0.01%
32
– –
2025 Q4
3 quarters
CMC icon
472
Commercial Metals
CMC
$6.87B
$2.8K ﹤0.01%
45
– –
2025 Q4
3 quarters
HSY icon
473
Hershey
HSY
$35.8B
$2.77K ﹤0.01%
18
– –
2025 Q4
3 quarters
HWKN icon
474
Hawkins
HWKN
$3.14B
$2.77K ﹤0.01%
22
– –
2025 Q4
3 quarters
INTU icon
475
Intuit
INTU
$91.3B
$2.76K ﹤0.01%
10
– –
2025 Q4
3 quarters

Similar funds

Torren Management's Q3 2026 Portfolio in Review

As of Q3 2026, Torren Management held 993 positions worth $201M, up 2.1% from $197M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Torren Management's Q3 2026 filing shows 45 new, 106 increased, 92 reduced and 48 closed positions. Its largest new stake was TSMC: 345 shares worth $157K. The largest sale was Dimensional Core Fixed Income ETF, an estimated $1.53M.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 96% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Torren Management's largest Q3 2026 buy was TSMC: 345 shares worth $157K.
  • Torren Management added most to Dimensional Short-Duration Fixed Income ETF in Q3 2026, an estimated $2.42M increase.
  • Torren Management's biggest Q3 2026 reduction was Dimensional Core Fixed Income ETF, cutting an estimated $1.53M.
  • Torren Management fully exited First Trust Rising Dividend Achievers ETF in Q3 2026, selling an estimated $110K.
  • Torren Management's ten largest holdings make up 83% of its $201M portfolio in Q3 2026.
  • Torren Management opened 45 new positions and closed 48 in Q3 2026.
  • Torren Management's portfolio value rose 2.1% quarter-over-quarter to $201M.

Based on Torren Management's 13F filing for Q3 2026, filed 29 Oct 2026.